Management of patients with rheumatoid arthritis in latin america: A consensus position paper from pan-american league of associations of rheumatology and grupo latino americano de estudio de artritis reumatoide

Journal of Clinical Rheumatology

Volumn 15, Issue 4, 2009, Pages 203-210

  Massardo, Loreto ^a   Suárez Almazor, María E ^b   Cardiel, Mario H ^c   Nava, Arnulfo ^d   Levy, Roger A ^e,f   Laurindo, Ieda ^g   Soriano, Enrique R ^h   Acevedo Vázquez, Eduardo ⁱ   Millán, Alberto ^j   Pineda Villaseñor, Carlos ^k   Galarza Maldonado, Claudio ^l   Caballero Uribe, Carlo V ^m   Espinosa Morales, Rolando ^k   Pons Estel, Bernardo A ⁿ  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c HOSPITAL GENERAL DR MIGUEL SILVA   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^e STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f Diagnósticos da América   (Brazil)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

ⁱ HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^j HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^k INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^l Hospital Monte Sinai   (Ecuador)

^m UNIVERSIDAD DEL NORTE   (Colombia)

ⁿ Hospital Provincial de Rosario   (Argentina)

more..

Author keywords

Diagnosis; Latin America; Rheumatoid arthritis; Treatment

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ARTICLE; CLINICAL DECISION MAKING; CONSENSUS; DRUG SAFETY; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PRACTITIONER; HEALTH SURVEY; MEDICAL RESEARCH; MEDICAL SOCIETY; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SOUTH AND CENTRAL AMERICA;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DATA COLLECTION; HEALTH EDUCATION; HEALTH POLICY; HUMANS; LATIN AMERICA; PATIENT EDUCATION AS TOPIC;

EID: 67650930350     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181a90cd8     Document Type: Article

References (51)

1. Kliksberg B. Social scenarios in Latin America and the Caribbean [in Spanish]. Rev Panam Salud Pública. 2000;8:105-111.
2. OPS. La Salud En Las Américas. Publicacion Científica y Técnica Número 587. Vol. 1. Washington, DC: Organización Panamericana de La Salud; 2002.
3. Cardiel MH. First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology (Oxford). 2006;45(suppl 2):ii7-ii22.
4. Marques J, Teixeira H, De Oliveira L, et al. Estudo multicéntrico da prevalencia da artrite reumatoide do adulto em amostras da populacao brasileira [in Portuguese]. Res Bras Reumatol. 1993;35:169-173.
5. Spindler A, Bellomio V, Berman A, et al. Prevalence of rheumatoid arthritis in Tucuman, Argentina. J Rheumatol. 2002;29:1166-1170.
6. Pons-Estel B; Grupo Latino Americano de estudio De Artritis Reumatoide (GLADAR). Latin American cohort of patients with early rheumatoid arthritis (ERA). [in Spanish]. Rev Chil Reumatol. 2005;21:165-172.
7. Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl. 1996;44:13-22.
8. Pincus T. Rheumatoid arthritis: a medical emergency? Scand J Rheumatol Suppl. 1994;100:21-30.
9. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis Rheum. 1998; 41:1072-1082.
10. Young A, Dixey J, Cox N, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford). 2000;39:603-611.
11. Jantti J, Aho K, Kaarela K, et al. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford). 1999;38:1138-1141.
12. Kobelt G, Eberhardt K, Jonsson L, et al. Economic consequences of the progression of rheumatoid arthritis in Sweden. Arthritis Rheum. 1999;42: 347-356.
13. Pugner KM, Scott Di, Holmes JW, et al. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum. 2000;29:305-320.
14. Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford). 2000;39:28-33.
15. Massardo L, Aguirre V, García ME, et al. Clinical expression of rheumatoid arthritis in Chilean patients. Semin Arthritis Rheum. 1995;25:203-213.
16. ERAS Study Group. Early Rheumatoid Arthritis Study. Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? Ann Rheum Dis. 2000;59:794-799.
17. Emery P. Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive? Br J Rheumatol. 1995;34(suppl 2):87-90.
18. Brook A, Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis. 1977;36:71-73.
19. Fuchs HA, Kaye JJ, Callahan LF, et al. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol. 1989;16:585-591.
20. Graudal NA, Jurik AG, De Carvalho A, et al. Radiographic progression in rheumatoid arthritis: a long-term prospective study of 109 patients. Arthritis Rheum. 1998;41:1470-1480.
21. Drossaers-Bakker KW, de Buck M, van Zeben D, et al. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum. 1999; 42:1854-1860.
22. Kirwan JR. Conceptual issues in scoring radiographic progression in rheumatoid arthritis. J Rheumatol. 1999;26:720-725.
23. Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford). 2000;39(suppl 1):24-29.
24. O'Dell JR. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum. 2002;46:283-285.
25. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol. 2003;21:S154-S157.
26. Machold KP, Eberl G, Leeb BF, et al. Early arthritis therapy: rationale and current approach. J Rheumatol Suppl. 1998;53:13-19.
27. Symmons DP, Jones MA, Scott DL, et al. Long term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol. 1998;25:1072-1077.
28. Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet. 1997;350: 309-318.
29. Mottonen T, Hannonen P, Leirisalo-Repo M, et al; FIN-RACo Trial Group. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet. 1999;353:1568-1573.
30. Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum. 2002;46:1443-1450.
31. Goekoop-Ruiterman YP, De Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005;52:3381-3390.
32. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum. 2002;46:328-346.
33. Bertolo M, Viegas C, Goldstein C, et al. Atualizacao do Consenso Brasileiro no Diagnostico e Tratamento da Artrite Reumatoide [in Portuguese]. Rev Bras Reumatol. 2007;47:5-16.
34. Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34-45.
35. Management of Early Rheumatoid Arthritis. Section 1: introduction. Edinburgh: Scottish Intercollegiate Guidelines Network; c2009. Available at: http://www.Sign.Ac.Uk/guidelines/fulltext/48/section1.html. Accessed February 4, 2009.
36. Grupo de Estudio de Artritis Reumatoidea; Sociedad Argentina de Reumatología. Actualizacion de las guías de practica clínica en el tratamiento de la artritis reumatoidea [in Spanish]. Rev Argent Reumatol. 2008;19,3:5-9. Available at: http://www.reumatologia.org. ar/userfiles/image/guias-practica-clinica/Guia-SAR-2008.pdf Accessed February 4, 2009.
37. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum. 1993;36: 439-446.
38. Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal antiinflammatory drug treatment. Arthritis Care Res. 1996;9: 292-301.
39. Holman HR, Lorig KR. Patient education: essential to good health care for patients with chronic arthritis. Arthritis Rheum. 1997;40:1371-1373.
40. Campbell SM, Braspenning J, Hutchinson A, et al. Research methods used in developing and applying quality indicators in primary care. BMJ. 2003;326: 816-819.
41. Gagliardi AR, Simunovic M, Langer B, et al. Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach. Can J Surg. 2005;48:441-452.
42. Brown N, Crawford I, Carley S, et al. A Delphi-based consensus study into planning for biological incidents. J Public Health (Oxf). 2006;28:238-241.
43. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
44. Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-48.
45. Hochberg MC, Chang RW, Dwosh I, et al. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992;35:498-502.
46. Szekanecz Z, Kerekes G, Der H, et al. Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci. 2007;1108:349-358.
47. Cisternas M, Gutierrez MA, Klaassen J, et al. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol. 2002;29:1619-1622.
48. Ministerio de Salud. Guía Clínica Artritis Reumatoidea. Santiago, Chile: MINSAL; 2007:1-41. Available at: http://www.redsalud.gov.cl/archivos/ guiasges/artritispdfpdf Accessed February 4, 2009.
49. Ministerio da Saúde. Sistema de Notificaç ões em Vigilância Sanitária - Notivisa. Brasilia: ANVISA. Available at: http://www.anvisa.gov.br/hotsite/ notivisa/index.htm. Accessed February 6 2009.
50. BIOBADAMERICA. Registro Panamericano de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas. Madrid, Spain: So-ciedad Española de Reumatologia. Available at: http://biobadaser.ser. es/ biobadamerica/index.html. Accessed February 6, 2009.
51. Harrison MJ, Deighton C, Symmons DP. An update on UK rheumatology consultant workforce provision: the BSR/ARC Workforce Register 2005-07: assessing the impact of recent changes in NHS provision. Rheumatology (Oxford). 2008;47:1065-1069.